1. 32 Safety, pharmacokinetics and pharmacodynamics of BI 705564, a covalent inhibitor of brutons tyrosine kinase in phase 1 clinical trials in healthy volunteers. (April 2019) Authors: Litzenburger, Tobias; Müller, Fabian; Schultz, Armin; Klein, Elliott; Ramanujam, Meera; Wu, Jing; Wiebe, Sabrina; Benediktus, Ewald; Hui, Jianan; Li, Xiujiang; Flack, Mary; Padula, Steven J; Visvanathan, Sudha; Steffgen, Jürgen; Hünnemeyer, Andreas Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Novel Tetrapeptide Derivative Exhibits In Vitro Inhibition of Neutrophil-Derived Reactive Oxygen Species and Lysosomal Enzymes Release. (30th May 2013) Authors: Miriyala, Sumitra; Panchatcharam, Manikandan; Ramanujam, Meera; Puvanakrishnan, Rengarajulu Other Names: Landar Aimee Academic Editor. Journal: Oxidative medicine and cellular longevity Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study. Issue 6 (22nd June 2019) Authors: Visvanathan, Sudha; Daniluk, Stefan; Ptaszyński, Rafał; Müller-Ladner, Ulf; Ramanujam, Meera; Rosenstock, Bernd; Eleftheraki, Anastasia G; Vinisko, Richard; Petříková, Alena; Kellner, Herbert; Dokoupilova, Eva; Kwiatkowska, Brygida; Alten, Rieke; Schwabe, Christian; Baum, Patrick; Joseph, David; ... Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 6(2019) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study. Issue 6 (22nd March 2019) Authors: Visvanathan, Sudha; Daniluk, Stefan; Ptaszyński, Rafał; Müller-Ladner, Ulf; Ramanujam, Meera; Rosenstock, Bernd; Eleftheraki, Anastasia G; Vinisko, Richard; Petříková, Alena; Kellner, Herbert; Dokoupilova, Eva; Kwiatkowska, Brygida; Alten, Rieke; Schwabe, Christian; Baum, Patrick; Joseph, David; ... Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 6(2019) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. II-06 Therapeutic blockade of immune complex-mediated glomerulonephritis by highly selective inhibition of bruton's tyrosine kinase. (31st August 2016) Authors: Chalmers, Sammy; Doerner, Jessica; Bosanac, Todd; Khalil, Sara; Smith, Dustin; Harcken, Christian; Dimock, Janice; Der, Evan; Herlitz, Leal; Webb, Deborah; Seccareccia, Elise; Feng, Di; Fine, Jay S; Ramanujam, Meera; Klein, Elliott; Putterman, Chaim Journal: Lupus science & medicine Issue: Volume 3(2016)Supplement 1 Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton's tyrosine kinase, in Phase I clinical trials in healthy volunteers. Issue 4 (20th November 2020) Authors: Litzenburger, Tobias; Steffgen, Jürgen; Benediktus, Ewald; Müller, Fabian; Schultz, Armin; Klein, Elliott; Ramanujam, Meera; Harcken, Christian; Gupta, Alpana; Wu, Jing; Wiebe, Sabrina; Li, Xiujiang; Flack, Mary; Padula, Steven J.; Visvanathan, Sudha; Hünnemeyer, Andreas; Hui, Jianan Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 4(2021) Page Start: 1824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Suppression of Glomerulonephritis in Lupus‐Prone NZB × NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase. Issue 9 (26th August 2013) Authors: Mina‐Osorio, Paola; LaStant, Jacob; Keirstead, Natalie; Whittard, Toni; Ayala, Julia; Stefanova, Stella; Garrido, Rosario; Dimaano, Nena; Hilton, Holly; Giron, Mario; Lau, Kai‐Yeung; Hang, Julie; Postelnek, Jennifer; Kim, Yong; Min, Soo; Patel, Alka; Woods, John; Ramanujam, Meera; DeMartino, Juli... Journal: Arthritis and rheumatism Issue: Volume 65:Issue 9(2013:Sep.) Page Start: 2380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Suppression of Glomerulonephritis in Lupus‐Prone NZB × NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase. Issue 9 (26th August 2013) Authors: Mina‐Osorio, Paola; LaStant, Jacob; Keirstead, Natalie; Whittard, Toni; Ayala, Julia; Stefanova, Stella; Garrido, Rosario; Dimaano, Nena; Hilton, Holly; Giron, Mario; Lau, Kai‐Yeung; Hang, Julie; Postelnek, Jennifer; Kim, Yong; Min, Soo; Patel, Alka; Woods, John; Ramanujam, Meera; DeMartino, Juli... Journal: Arthritis and rheumatism Issue: Volume 65:Issue 9(2013:Sep.) Page Start: 2380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The Janus of Oxidative Stress Signaling in Different Pathophysiological Conditions. (19th June 2013) Authors: Miriyala, Sumitra; Panchatcharam, Manikandan; Landar, Aimee; Ramanujam, Meera; Chatterjee, Saurabh; Muthuswamy, Anantharaman Journal: Oxidative medicine and cellular longevity Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗